The Emergent Growth Funds are member-managed angel funds that share the same focus on early stage companies.
The Emergent Growth Funds are member-managed angel funds that share the same focus on early stage companies. The current funds concentrate their activities on companies that are developing unique, leading-edge products, or proprietary technologies that possess the potential for rapid growth in significant markets.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Mar 28, 2018
Clinipace
|
Series Unknown | $19.90M | Biotechnology | — |
Mar 15, 2010
BACCH Labs
|
Series A | $1M | 3D Technology | Yes |
Mar 20, 2008
SplashCast
|
Series A | $4M | Advertising | — |
Jan 14, 2008
Clinipace
|
Series B | $2.60M | Biotechnology | — |
Jan 11, 2008
AerovectRx
|
Seed | $1.20M | Health Care | — |